University of California, Los Angeles
Dr. Aaron Lisberg is a hematologist and medical oncologist at the University of California, Los Angeles (UCLA). He specializes in novel drug development, immunotherapy, and metabolically targeted therapies in patients with thoracic malignancies. He is board certified in internal medicine, hematology and medical oncology. Dr. Lisberg received his medical degree from the University of Minnesota Medical School, where he was elected to the AOA honor society. He then completed his internal medicine residency at The University of Washington in Seattle, followed by his hematology/oncology fellowship at UCLA.
Dr. Lisberg conducts translational research on novel therapeutic approaches in thoracic malignancies. He has a wide range of ongoing research projects including evaluation of factors predictive of response or toxicity to immune checkpoint inhibition, pre-clinical/clinical evaluation of novel metabolic therapies, and assessment of effective treatments in patients with targetable tumor alterations. He is also the clinical PI and Sub-I of several clinical trials evaluating novel therapeutics in a variety of malignancies, including Phase I, II, and III assessments.
Wednesday, November 29, 2023
4:45 PM – 5:20 PM ET
Wednesday, November 29, 2023
5:20 PM – 5:30 PM ET